ReCap Total Hip Resurfacing Prospective Data Collection

This study is currently recruiting participants.

Verified September 2011 by Biomet, Inc.

First Received on September 23, 2008. Last Updated on September 27, 2011 History of Changes

Sponsor:	Biomet, Inc.
Collaborator:	Biomet U.K. Ltd.
Information provided by (Responsible Party):	Biomet, Inc.
ClinicalTrials.gov Identifier:	NCT00758472

Purpose

Prospective data collection on survivorship of ReCap Total Hip Resurfacing

Condition	Intervention
Arthritis	Device: ReCap Total Hip Resurfacing

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	ReCap Total Hip Resurfacing Prospective Data Collection

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:

Estimated Enrollment:	500
Study Start Date:	March 2005
Estimated Study Completion Date:	March 2020
Estimated Primary Completion Date:	March 2020 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
Hip Resurfacing	Device: ReCap Total Hip Resurfacing ReCap Total Hip Resurfacing Other Name: RECAP

Detailed Description:

Detailed protocol not available

Eligibility

Study Population

Patients suitable for Total Hip Resurfacing

Criteria

Inclusion Criteria:

Exclusion criteria:

- less than 18 years of age

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00758472

Locations

United Kingdom
Southmead Hospital	Recruiting
Bristol, United Kingdom
Contact: E J Smith, FRCS 0117 950 5050
Robert Jones & Agnes Hunt Orthopaedic & District Hospital NHS Trust	Recruiting
Oswestry, United Kingdom
Contact: S Karlakki, FRCS 01691 404000

Sponsors and Collaborators

Biomet, Inc.

Biomet U.K. Ltd.

Investigators

Principal Investigator:

Evert Smith, MD

North Bristol NHS Trust

More Information

No publications provided

Responsible Party:	Biomet, Inc.
ClinicalTrials.gov Identifier:	NCT00758472 History of Changes
Other Study ID Numbers:	BMET UK 08
Study First Received:	September 23, 2008
Last Updated:	September 27, 2011
Health Authority:	United Kingdom: Medicines and Healthcare Products Regulatory Agency

Additional relevant MeSH terms:

Arthritis
Joint Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on February 09, 2012